Kidney Transplant Infection Clinical Trial
Official title:
The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus in Treatment of BK Virus Infection in Kidney Transplantation Recipient
BK virus infection is one of the causes of renal allograft loss in the current era. Reduction of immunsuppression is the only intervention that prooved to be effective in treating of BK virus in kidney transplant recipient. However, there are evidences from retrospective and prospective studies showed that leflunomide and mTOR inhibitor such as everolimus or sirolimus have positive outcomes in treatment of BK virus in kidney tranplant recipient. The investigators conduct the RCT to compare the efficacy of leflunomide and mTOR inhibitor everolimus, in treatment of BK virus infected patients who do not respond to immunosuppression reduction.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02439957 -
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
|
Phase 3 | |
Not yet recruiting |
NCT06364618 -
Use of Wearables to Detect Infections in Kidney Transplant Recipients
|
||
Completed |
NCT05142748 -
Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital
|
||
Terminated |
NCT05747053 -
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
|
||
Completed |
NCT03339661 -
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring.
|
Phase 2 | |
Enrolling by invitation |
NCT05224583 -
Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
|
||
Recruiting |
NCT04701528 -
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
|
Phase 2 | |
Recruiting |
NCT04494776 -
SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
|
||
Completed |
NCT02263703 -
Immunogenicity of HPV Vaccine in Immunosuppressed Children
|
Phase 3 | |
Recruiting |
NCT06219616 -
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
|
N/A | |
Not yet recruiting |
NCT05708534 -
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
|
||
Recruiting |
NCT03488771 -
Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients
|
||
Recruiting |
NCT04815954 -
Early vs Late Urinary Catheter Removal After Renal Transplantation
|
N/A | |
Recruiting |
NCT05727709 -
Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
|
||
Completed |
NCT04542954 -
Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
|
||
Active, not recruiting |
NCT03924219 -
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
|
||
Recruiting |
NCT05836636 -
Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
|
||
Not yet recruiting |
NCT06407232 -
Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
|
Phase 3 | |
Completed |
NCT03468478 -
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
|
Phase 4 | |
Recruiting |
NCT05397821 -
Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
|